Clinical trials: innovation, progress and controversy

Clinical trials: innovation, progress and controversy Editorial (4395) Total Article Views Authors: Martin GS Published Date August 2011 Volume 2011:3 Pages 43 - 44 DOI: http://dx.doi.org/10.2147/OAJCT.S22967 Greg S Martin Department of Pulmonary, Allergy and Critical Care, Emory University, Atlanta, Georgia, USA The Open Access Journal of Clinical Trials began in 2009 with the goal of being an authoritative, open access source for international, peer-reviewed publications in the field of human research and clinical trials. Since then, the Open Access Journal of Clinical Trials has published approximately 30 high-quality articles on original research, innovative reviews, and critical commentaries. These articles have spanned many aspects of clinical trials wonderfully, including trial design and management; legal, ethical and regulatory issues of clinical trials; subject participation and retention in clinical trials; and data collection and data management. Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Other articles by Professor Greg Martin Critical illness outcome study: an observational study of protocols and mortality in intensive care units Readers of this article also read: Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations Examining the readability of patient-informed consent forms The future of the pharmaceutical, biological and medical device industry Examining the clinical trial feasibility process and its implications for a trial site Assessment of the efficacy of first-line antimalarial drugs after 5 years of deployment by the National Malaria Control Programme in C te d'Ivoire A self-assembling peptide RADA16-I integrated with spider fibroin uncrystalline motifs Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure Functional coating of liposomes using a folate–polymer conjugate to target folate receptors Biology and natural history of human papillomavirus infection The role of technology in avoiding bias in the design and execution of clinical trials